The list of publications in 2017
1. Novik A.A., Ionova T.A. Quality of Life Research in Pediatrics (3rd edition, processed and added) / ed. by Academ J.L Shevchenko. Moscow: RAEN Publishers, 2017. 184 p. (In Russian)
2. Ionova T., Bulieva N., Vinogradova O., Zinkovskaya A., Lipatova D., Lomaia E., Nikitina T., Novitskaya N., Trifonova E., Usacheva E., Chukavina M., Shumkova M. Quality of Life (QoL), Efficacy and Safety of Treatment with Dasatinib as Front-line Therapy or after Early Switching from Imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CP CML): a Real World Data. Clinical Hematology. 2017; 10 (2): 206–17. DOI: 10.21320/2500-2139-2017-10-2-206-217 (in Russian).
3. Ionova T.I. Modern trends in quality of life research in Health care in Russia. Bulletin of Pirogov National Medical and Surgical Center. 2017; 12 (3, Supplement): Ð. 9 (in Russian).
4. Fedorenko D.A., Faddeev N.M., Melnichenko V.Y., Ionova T.I. Comprehensive evaluation of the outcomes of autologous hematopoietic stem cell transplantation in lymphoma patients: significance of quality of life assessment. Bulletin of Pirogov National Medical and Surgical Center. 2017; 12 (3, Supplement): 11–14 (in Russian).
5. Tseitlin G.Ya., Kokoreva M.E., Borodina I.D., Karelin A.F., Nikitina T.P., Ionova T.I. Quality of life in children with cancer in remission and in their families after finishing anticancer treatment. Bulletin of Pirogov National Medical and Surgical Center. 2017; 12 (3, Supplement): 15–18 (in Russian).
6. Usoltseva E.N., Ionova T.I. Quality of life in women of the Chelyabinsk city with pathological climacteric period in comparison with population data. Bulletin of Pirogov National Medical and Surgical Center. 2017; 12 (3, Supplement): Ð. 51 (in Russian).
7. Fedotova O.N., Ionova T.I., Yuryev V.K. Quality of life features in patients with chronic pulmonary diseases. Bulletin of Pirogov National Medical and Surgical Center. 2017; 12 (3, Supplement): 52–55 (in Russian).
8. Nikitina T.P., Ionova T.I. Modern approaches for interpreting quality of life data in pediatrics: from research to clinical practice. 2017; 12 (3, Supplement): 78–80 (in Russian).
9. Ionova T.I., Nikitina T.P. Modern approaches for interpreting quality of life data in pediatrics. Bulletin of the Multinational Center for Quality of Life Research. 2017; 29-30: 5–9 (in Russian).
10. Ionova T.I., Bulieva N.B., Vinogradova O.Yu., Golenkov A.K., Gritsenko T.A., Zinkovskaya A.V., Kozlova L.K., Kuchma G.B., Lipatova D.A., Lomaia E.G., Machulaytene E.R., Nikitina T.P., Novitskaya N.V., Trifonova E.V., Usacheva E.I., Shneider T.V. Quality of life and symptoms in patients with chronic myeloid leukemia in chronic phase during target treatment (dasatinib as first and second line therapy) in a real world setting. Bulletin of the Multinational Center for Quality of Life Research. 2017; 29-30: 21–32 (in Russian).
11. Ionova T.I., Nikitina T.P. Population-based studies of pediatric quality of life. Bulletin of the Multinational Center for Quality of Life Research. 2017; 29-30: 69–75 (in Russian).
12. Ionova T.I., Bolotina L.V., Breder V.V., Danilova A.S., Zinkovskaya A.V., Lipatova D.A., Malova O.A., Moiseenko F.V., Nikitina T.P., Orlova R.V., S.A. Protsenko, E.A. Filippova, K.K. Laktionov. Quality of life and symptoms in patients with advanced refractory non-small cell lung cancer. Bulletin of the Multinational Center for Quality of Life Research. 2017; 29-30: 76–82 (in Russian).
13. Zinkovskaya A.V., Ionova T.I. Important statistical task in quality of life research. Bulletin of the Multinational Center for Quality of Life Research. 2017; 29-30: 83–89 (in Russian).
14. Ionova T.I., Nikitina T.P., Novik A.A., Snegovoy A.V. Practical guidelines for assessment of fatigue in patients with cancer. Malignant tumors: RUSSCO Guidelines #3s2, 2017 (Vol. 7): 582–585.
15. Ionova T.I., Nikitina T.P., Novik A.A., Snegovoy A.V. Practical guidelines for assessment of fatigue in patients with cancer. Malignant tumors: RUSSCO #3s2, 2017 (òîì 7): 586–591.
16. Laktionov K.K., Bolotina L.V., Breder V.V., Danilova A.S., Moiseenko F.V., Nikitina T.P., Orlova R.V., Filippova E.A., Protsenko S.A., Ionova T.I. Clinical outcomes and quality of life (QoL) in adults with advanced refractory non-small cell lung cancer (NSCLC) patients receiving nivolumab (Nivo) as 2+ line treatment: interim analysis of expanded access program. Annals of Oncology. 2017; 28 (Suppl.2): P. 41. doi:10.1093/annonc/mdx091. https://academic.oup.com/annonc/article/28/suppl_2/mdx091.033/3799695?searchresult=1
17. Tseitlin G., Karelin G., Borodina I., Kokoreva M., Ionova T., Nikitina T. Health-related quality of life in children with brain tumors and acute lymphoblastic leukemia after treatment: a comparative study. Abstracts of the 2017 World Congress of Psycho-oncology, 14-18 August 2017, Berlin, Germany. Psycho-Oncology. 2017; 26 (Suppl. 3): P. 28. http://www.ipos2017.com/files/content/downloads/IPOS2017_Abstractbook_.pdf
18. Ionova T., Bulieva N., Vinogradova O., Zinkovskaya A., Lipatova D., Lomaia E., Nikitina T., Novitskaya N., Trifonova E., Usacheva E., Chukavina M., Shumkova M. Quality of Life (QoL), Efficacy and Safety of Treatment with Dasatinib as Front-line Therapy or after Early Switching from Imatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CP CML): a Real World Data. Clinicheskaya onkogematologia. 2017; 10 (4): 546–547. http://bloodjournal.ru/wp-content/uploads/2017/10/12_1.pdf
19. Ionova T., Bulieva N., Vinogradova O., Gritsenko T., Zinkovskaya A., Kozlova L., Kuchma G., Lipatova D., Lomaia E., Machulaytene E., Nikitina T., Novitskaya N., Trifonova E., Usacheva E., Shneider T. Impact of symptom burden on quality of life (QoL) in patients with chronic myeloid leukemia in chronic phase (CML CP). Clinicheskaya onkogematologia. 2017; 10 (4): 548–549.http://bloodjournal.ru/wp-content/uploads/2017/10/12_1.pdf
20. Moiseenko F.V., Laktionov K.K., Arzumanyan A.L. et al. Observational study of the efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: interim analysis. J Clin Oncol. 2017; 35 (Suppl; abstr e14593). https://meetinglibrary.asco.org/record/145234/abstract
21. Laktionov K.K., Arzumanyan A.L., Bolotina L.V., Breder V.V., Buevich N.N., Danilova A.S., Filippova E.A., Kornietskaya A.L., Kramchaninov M.M., Kushniruk E.K., Latipova D.H., Lipatova D.A., Moiseenko F.V., Nikitina T.P., Orlov S.V., Orlova R.V., Protsenko S.A., Sarantseva K.A., Stroyakovskiy D.L., Ionova T.I. Efficacy of nivolumab as second and further line of treatment and quality of life in patients with advanced refractory non-small cell lung cancer: interim results of prospective observational study. Proceedings of III St. Petersburg International Oncology Forum "White Nights 2017», 91–92 (in Russian)
22. Laktionov K.K., Arzumanyan A.L., Bolotina L.V., Breder V.V., Buevich N.N., Danilova A.S., Filippova E.A., Kornietskaya A.L., Kramchaninov M.M., Kushniruk E.K., Latipova D.H., Moiseenko F.V., Nikitina T.P., Orlov S.V., Orlova R.V., Protsenko S.A., Sarantseva K.A., Stroyakovskiy D.L., Ionova T.I. Multicenter observational study of the efficacy and safety of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: interim analysis. Annals of Oncology. 2017; 28 (Suppl. 5): P. 470. https://academic.oup.com/annonc/article/28/suppl_5/mdx380.020/4109375?searchresult=1
23. Ionova T.I., Arzumanyan A.L., Bolotina L.V., Breder V.V., Buevich N.N., Danilova A.S., Filippova E.A., Kornietskaya A.L., Kramchaninov M.M., Kushniruk E.K., Latipova D.H., Lipatova D.A. , Malova O.A., Moiseenko F.V., Nikitina T.P., Orlov S.V., Orlova R.V., Protsenko S.A., Sarantseva K.A., Stroyakovskiy D.L., Zinkovskaya A.V., Laktionov K.K. Quality of life and clinical outcomes of nivolumab as 2+ line treatment in advanced refractory NSCLC pts: interim analysis. Journal of Thoracic Oncology. 2017; Vol. 12 (¹11, Supplement 2): P. 1916. http://www.jto.org/article/S1556-0864(17)31445-4/fulltext
24. Tseitlin G., Karelin G., Borodina I., Kokoreva M., Nikitina T. Ionova T. Quality of life assessment in children and adolescents with cancer as a criterion of effectiveness of rehabilitation. Proceeding of the Ist National Congress with International Participation «Rehabilitation – ÕÕI Century: traditions and innovations». 2017; 270–271. (in Russian)
25. Ionova T.I., Arzumanyan A.L., Bolotina L.V., Breder V.V., Buevich N.N., Danilova A.S., Filippova E.A., Kornietskaya A.L., Kramchaninov M.M., Kushniruk E.K., Latipova D.H., Lipatova D.A., Malova O.A., Moiseenko F.V., Nikitina T.P., Orlov S.V., Orlova R.V., Protsenko S.A., Sarantseva K.A., Stroyakovskiy D.L., Zinkovskaya A.V., Laktionov K.K. Quality of life and clinical outcomes of nivolumab as 2+ line treatment in advanced refractory NSCLC pts: interim analysis. Abstract Book of IASLC 18th World Congress of Lung Cancer, 2017, P. 227. https://s3.amazonaws.com/iaslc/pdf/WCLC2017_Abstract_Book_Web.pdf
26. IonovaT., BulievaN., GolenkovA., GritsenkoT., KozlovaL., KuchmaG., LomaiaE., MachulayteneE., NikitinaT., NovitskayaN., UsachevaE., ShneiderT., TrifonovaE., VinogradovaO., ZinkovskayaA.. Is quality of life (QOL) predictive for clinical response in chronic phase-chronic myeloid leukemia (CP-CML) patients treated with dasatinib? Blood. 2017; 130 (Suppl 1); 2181. http://www.bloodjournal.org/content/130/Suppl_1/2181
27. P. Goswami, S. Salek, T. Ionova, E. Oliva, A. Fielding, M. Karakantza, S. Al-Ismail, G. Collins, S. McCpnnell, C. Langton, D. Jennings, R. Else, W. Kell. HM-PRO: A Novel Patient-Reported Outcome Measure in Hematological Malignancy for Use in Clinical Practice. Blood. 2017; 130 (Suppl 1):2176. http://www.bloodjournal.org/content/130/Suppl_1/2176
|
